Aetna is one of the major California insurance carriers accepted at California Bladder's San Diego locations — and yes, Aetna covers sacral neuromodulation when clinical criteria are met. Here's what San Diego Aetna members need to know about the coverage criteria and process.
Aetna's Coverage Policy: CPB 0223
Aetna considers sacral nerve stimulation medically necessary under Clinical Policy Bulletin 0223 for appropriate OAB and urinary incontinence indications. Coverage applies for FDA-approved sacral nerve stimulation devices including InterStim and Axonics.
Aetna's Criteria for California SNM Coverage
Aetna requires documentation of: the appropriate diagnosis (urge urinary incontinence, urgency-frequency syndrome, or non-obstructive urinary retention); failure of appropriate conservative treatments (behavioral therapy and/or medications); and a successful trial stimulation with at least 50% decrease in symptoms as the threshold. For urinary retention, the condition must have persisted for at least 6 months.
The Trial Stimulation Requirement
Like Medicare, Aetna requires a trial stimulation period before covering the permanent implant. The trial demonstrates that the device actually helps you — and Aetna uses the trial outcome data to authorize the permanent procedure. Our San Diego team prepares and submits this documentation as part of the prior authorization process.
Aetna and OAB Medications
Aetna typically expects documentation that appropriate first-line and second-line OAB treatments (behavioral therapy, medications) were tried before advancing to SNM. Documented medication intolerance or inadequate response — including dry mouth, constipation, cognitive concerns, or insufficient symptom relief — satisfies this requirement. Our San Diego team helps ensure this clinical history is accurately captured in your record before submitting the authorization request.
Call California Bladder at (858) 571-3630 to schedule at our San Diego area locations. We handle Aetna prior authorization from start to finish.
This article is for informational purposes only and does not constitute medical advice. Coverage information is general; individual plan requirements vary. A clinical evaluation is required.